Skip to content

Paravertebral Blocks: Pilot Study to Compare Nerve Stimulation vs. Anatomic Landmarks in Inguinal Hernia Repair

Paravertebral Blocks Techniques: A Pilot Study to Compare Nerve Stimulation vs. Anatomic Landmarks for Patients Undergoing Inguinal Hernia Repair

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00587704
Acronym
PVB
Enrollment
50
Registered
2008-01-07
Start date
2007-07-31
Completion date
2009-05-31
Last updated
2010-02-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inguinal Hernia

Brief summary

Primary aim: 1\. To compare the nerve stimulation vs. anatomic techniques of paravertebral block of T11-L1 in providing surgical anesthesia for patients undergoing inguinal hernia repair. Secondary aims: 1. Compare VAS pain scores in the two groups of patients over the first 24 hours. 2. Compare opioid intake over the first 24 hours in the two groups of patients.

Interventions

PROCEDUREPVB using nerve stimulation

5ml of 1% ropivacaine injected incrementally

PROCEDUREPVB using anatomic landmarks

5ml of 1% ropivacaine injected incrementally

Sponsors

Mayo Clinic
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Unilateral open inguinal herniorrhaphy * Patient must be \>18 years of age * ASA physical status of I, II, or III * Patient competent to provide informed consent

Exclusion criteria

* Patient \< 18 years of age * Pregnant or lactating women * Patient unwilling or unable to provide informed consent * Contraindications to regional anesthesia * Allergy to amide local anesthetics

Design outcomes

Primary

MeasureTime frame
Successful full block at T11-L1Every 10 minutes until full block achieved

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026